Chlamydia in Emergency Medicine
- Author: Debra E Houry, MD, MPH; Chief Editor: Rick Kulkarni, MD more...
Background
Chlamydia trachomatis is an obligate, intracellular bacterium with 15 immunotypes, as follows: A-C cause trachoma (chronic conjunctivitis endemic in Africa and Asia); D-K, genital tract infections; and L1-L3, lymphogranuloma venereum (associated with genital ulcer disease in tropical countries). Chlamydia is the most commonly reported bacterial sexually transmitted disease (STD) in the United States and is one of the leading causes of infertility in women.
The US Preventive Services Task Force recommends the following:[1, 2] (1) screening for chlamydial infection in all sexually active nonpregnant young women aged 24 years or younger and for older nonpregnant women who are at increased risk; (2) screening for chlamydial infection in all pregnant women aged 24 years or younger and in older pregnant women who are at increased risk; and (3) not routinely screening for chlamydial infection in women aged 25 years or older, regardless of whether they are pregnant, if they are not at increased risk. Also see these guidelines at the National Guideline Clearinghouse.
Routine chlamydia screening of sexually active young women is recommended to prevent consequences of untreated chlamydial infection (eg, pelvic inflammatory disease, infertility, ectopic pregnancy, chronic pelvic pain). Fewer than half of young, sexually active females in the United States are screened for chlamydia, reports MMWR. Nationally, the annual screening rate increased from 25.3% in 2000 to 43.6% in 2006, and then decreased slightly to 41.6% in 2007.[3]
Pathophysiology
Infection of the genital tract is the most common clinical presentation. The incubation period is 1-3 weeks. Approximately 50% of infected males and 80% of infected females are asymptomatic, but infection may cause a mucopurulent cervicitis in females and urethritis in males. Ascending infection can result in pelvic inflammatory disease (PID) in women and is the most common cause of epididymitis in men younger than 35 years. Of women with PID, 5-10% develop perihepatitis (ie, Fitz-Hugh-Curtis syndrome). Fitz-Hugh-Curtis syndrome is shown in the CTs below.
CT scan of an adolescent with chlamydial Fitz-Hugh-Curtis syndrome demonstrating a perihepatic fluid collection anterior to the liver.
CT scan of an adolescent with chlamydial Fitz-Hugh-Curtis syndrome demonstrating free peritoneal fluid. Although patients with any sexually transmitted disease (STD) are at increased risk of co-infection with another STD, co-infection of chlamydia and gonorrhea is most common. Forty percent of women and 20% of men with chlamydial infection are co-infected with gonorrhea. Patients with chlamydia also have a higher frequency of Reiter syndrome (ie, urethritis, conjunctivitis, reactive arthritis) than the general population.
Lymphogranuloma venereum is rare in the US but is responsible for 10% of genital ulcer disease in tropical countries. Localized inguinal adenopathy and ulceration develop 2-12 weeks after exposure. Proctitis, rectal strictures, and lymphatic obstruction with secondary elephantiasis can occur in untreated disease.
Chlamydia is transmitted via the birth canal of an infected mother, and neonates exposed to chlamydia at birth may develop conjunctivitis 5-13 days later. C trachomatis immunotypes A-C, which are endemic in Africa, cause a chronic conjunctivitis.
C trachomatis is one of the most common causes of pneumonia in the newborn. Chlamydial infection develops in 60% of neonates born vaginally to infected mothers.
Epidemiology
Frequency
United States
Approximately 4 million cases of chlamydial infection are reported per year in the United States, with an overall prevalence of 5%. At-risk groups (eg, sexually active adolescent girls) have a higher prevalence, with an incidence of 10%. A prevalence of chlamydia as high as 14% has been reported in African American females aged 18-26 years and 17% among females with a history of gonorrhea or chlamydia in the previous 12 months. In addition, approximately 100,000 neonates are exposed to chlamydia annually.
Mortality/Morbidity
Chlamydial infection is one of the leading causes of infertility in women. Other long-term problems caused by chlamydial infection include PID, chronic pelvic pain, and perihepatitis. Women with a chlamydial infection (especially serotype G) are at an increased risk of developing cervical cancer; risk is as high as 6.5 times greater than in women without infection. Untreated neonatal conjunctivitis can result in blindness.
Race
The disease is more common among minorities, lower socioeconomic groups, and people living in urban areas than in the general population.
Sex
Women are more likely to be asymptomatic than men (80% vs 50%). However, women are more likely to develop long-term complications (eg, PID, infertility).
Age
Prevalence rates are highest in adolescent girls (>10%).
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Jul 17 2007;147(2):128-34. [Medline]. [Full Text].
Screening for chlamydial infection: recommendation statement. National Guideline Clearinghouse. Available at http://guideline.gov/summary/summary.aspx?doc_id=10408. Accessed March 23, 2009.
Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007. MMWR Morb Mortal Wkly Rep. Apr 17 2009;58(14):362-5. [Medline]. [Full Text].
(1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. National Guideline Clearinghouse. Available at http://guideline.gov/summary/summary.aspx?doc_id=10769. Accessed March 23, 2009.
Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. Jan 3 2001;285(1):47-51. [Medline].
CDC. Sexually transmitted diseases treatment guidelines 2006. Centers for Disease Control and Prevention. MMWR Recomm Rep. Aug 4 2006;55(RR-11):1-94. [Medline].
Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis. Oct 2005;16(4):235-44. [Medline].
Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. Jul 17 2007;147(2):89-96. [Medline].
Jensen JS, Bjornelius E, Dohn B, Lidbrink P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis. Aug 2004;31(8):499-507. [Medline].
Kelly JJ, Dalsey WC, McComb J, Njuki F. Follow-up program for emergency department patients with gonorrhea or chlamydia. Acad Emerg Med. Dec 2000;7(12):1437-9. [Medline].
Magid D, Douglas JM Jr, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med. Feb 15 1996;124(4):389-99. [Medline].
Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. May 12 2004;291(18):2229-36. [Medline].
Stewart DP. Historical, physical, and laboratory characteristics of female ED patients with positive chlamydia and gonorrhea cultures. Am J Emerg Med. May 1996;14(3):336-7. [Medline].

